About 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one
1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one (PubChem CID 166165563) has the molecular formula C26H22ClF3N4O3
and a molecular weight of 530.93 g/mol. Its IUPAC name is 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one.
Molecular Properties
| Compound Name | 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one |
| PubChem CID | 166165563 |
| Molecular Formula | C26H22ClF3N4O3 |
| Molecular Weight | 530.93 g/mol |
| Exact Mass | 530.13 |
| IUPAC Name | 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one |
| SMILES | Cn1ccn(-c2ccc(-c3cc(F)cc(-c4ccnc(N5CC(F)(F)[C@@](C)(O)C5)c4)c3O)cc2Cl)c1=O |
| InChI | InChI=1S/C26H22ClF3N4O3/c1-25(37)13-33(14-26(25,29)30)22-10-16(5-6-31-22)19-12-17(28)11-18(23(19)35)15-3-4-21(20(27)9-15)34-8-7-32(2)24(34)36/h3-12,35,37H,13-14H2,1-2H3/t25-/m0/s1 |
| InChIKey | JUGFALSGOODZOQ-VWLOTQADSA-N |
| XLogP | 4.61 |
| TPSA | 83.52 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 530.93 |
| LogP ≤ 5 | 4.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one?
The IUPAC name of 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one (CID 166165563) is 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one.
What is the SMILES notation for 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one?
The canonical SMILES for 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one is Cn1ccn(-c2ccc(-c3cc(F)cc(-c4ccnc(N5CC(F)(F)[C@@](C)(O)C5)c4)c3O)cc2Cl)c1=O.
What is the InChIKey of 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one?
The InChIKey is JUGFALSGOODZOQ-VWLOTQADSA-N. The full InChI is InChI=1S/C26H22ClF3N4O3/c1-25(37)13-33(14-26(25,29)30)22-10-16(5-6-31-22)19-12-17(28)11-18(23(19)35)15-3-4-21(20(27)9-15)34-8-7-32(2)24(34)36/h3-12,35,37H,13-14H2,1-2H3/t25-/m0/s1.
What are the key properties of 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one?
1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one has a molecular weight of 530.93 g/mol, XLogP of 4.61, 4 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-chloro-4-[3-[2-[(4S)-3,3-difluoro-4-hydroxy-4-methylpyrrolidin-1-yl]-4-pyridinyl]-5-fluoro-2-hydroxyphenyl]phenyl]-3-methylimidazol-2-one is sourced from PubChem (CID 166165563), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).